Gating on CD4 and CD25 with subsequent gating on FOXP3 confirmed the already described increase of Treg cells in patients with CRC, CLL, MGUS, MM, FL, and HD (Figures 3(a) and 3(b) and Tables 3 and 4). This evidence concerns the gene IL2RA and colorectal carcinoma.